APERAM S.A. NY SHS/1 O.N. Capital Reinvestment Ratio

Latest as of June 2026: 0.26x

APERAM S.A. NY SHS/1 O.N. capital reinvestment ratio. APERAM S.A. NY SHS/1 O.N. (7AAN) has a Capital Reinvestment Ratio of 0.26x as of June 2026, meaning it reinvests 0% of its operating cash flow (€139.00 Million) in capital expenditures (€36.00 Million). See 7AAN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

€139.00 Million
EUR

Capital Expenditures

€36.00 Million
EUR

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of APERAM S.A. NY SHS/1 O.N. (2022–2025)

Capital reinvestment ratio of APERAM S.A. NY SHS/1 O.N. from 2022 to 2025. This chart tracks APERAM S.A. NY SHS/1 O.N.'s Capital Reinvestment Ratio across 4 annual periods. See financial agility of APERAM S.A. NY SHS/1 O.N. to measure the company's free cash flow as a share of total liabilities.

APERAM S.A. NY SHS/1 O.N. Capital Reinvestment Ratio by Year (2022–2025)

APERAM S.A. NY SHS/1 O.N. capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see APERAM S.A. NY SHS/1 O.N. operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.41x €422.00 Million €174.00 Million ▼ -25.5%
2024 0.55x €280.00 Million €155.00 Million ▼ -13.4%
2023 0.64x €471.00 Million €301.00 Million ▲ +38.6%
2022 0.46x €642.00 Million €296.00 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow